GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matricelf Ltd (XTAE:MTLF) » Definitions » EV-to-EBITDA

Matricelf (XTAE:MTLF) EV-to-EBITDA : (As of Jun. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Matricelf EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Matricelf's enterprise value is ₪47.50 Mil. Matricelf does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Matricelf's EV-to-EBITDA at this moment.

The historical rank and industry rank for Matricelf's EV-to-EBITDA or its related term are showing as below:

XTAE:MTLF's EV-to-EBITDA is not ranked *
in the Biotechnology industry.
Industry Median: 8.64
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-02), Matricelf's stock price is ₪2.94. Matricelf does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Matricelf's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Matricelf EV-to-EBITDA Historical Data

The historical data trend for Matricelf's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matricelf EV-to-EBITDA Chart

Matricelf Annual Data
Trend
EV-to-EBITDA

Matricelf Semi-Annual Data
EV-to-EBITDA

Competitive Comparison of Matricelf's EV-to-EBITDA

For the Biotechnology subindustry, Matricelf's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Matricelf's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Matricelf's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Matricelf's EV-to-EBITDA falls into.


;
;

Matricelf EV-to-EBITDA Calculation

Matricelf's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=47.504/
=


Matricelf  (XTAE:MTLF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Matricelf's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.94/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Matricelf EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Matricelf's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Matricelf Business Description

Traded in Other Exchanges
N/A
Address
Golda Meir 3, Ness Ziona, ISR, 6701838
Matricelf Ltd is engaged in research and development in the field of medicine and tissue engineering. It is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions.

Matricelf Headlines

No Headlines